Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maria Eva Perez‐Lopez"'
Autor:
Raquel Veiga‐Seijo, Sonia Pertega‐Diaz, Maria Eva Perez‐Lopez, Lourdes Calvo Martinez, Silvia Antolin Novoa, Cristina Gonzalez‐Martin
Publikováno v:
Journal of Foot and Ankle Research, Vol 16, Iss 1, Pp n/a-n/a (2023)
Abstract Background Chemotherapy is one of the most widely used therapies for breast cancer, triggering important repercussions on people's quality of life. However, little research has been undertaken about podiatric adverse effects. This study aime
Externí odkaz:
https://doaj.org/article/3637dde9645d4c819d70af7c92ce0b73
Autor:
Raquel Veiga-Seijo, Maria Eva Perez-Lopez, Uxia Fernandez-Lopez, Abian Mosquera-Fernandez, Rocio Seijo-Bestilleiro, Cristina Gonzalez-Martin
Publikováno v:
Cancers, Vol 15, Iss 7, p 2110 (2023)
Background: Chemotherapy-induced peripheral neuropathy is a multidimensional health problem. Up to now, little evidence has been found concerning its impact on quality of life and foot health. Evaluation tools and prevention and treatment strategies
Externí odkaz:
https://doaj.org/article/49fb62f3a42948aea36a425e7cd7e1e7
Autor:
Judith Balmaña, Tomás Pascual, Alba Llop-Guevara, Pablo Tolosa, Isabel Blancas, Maria-Eva Perez-Lopez, Barbara Adamo, Iris Teruel, Jose Ponce, Marta Gonzalez, Gemma Viñas, Laura Lema, Francisco Javier Salvador, Mª Teresa Martinez, Alejandra Espinosa, Aleix Prat, Violeta Serra
Publikováno v:
Cancer Research. 83:OT3-11
Background The OlympiAD trial evaluated the PARP inhibitor (PARPi) olaparib versus a non-platinum standard chemotherapy in HER2-negative metastatic breast cancer (MBC) patients with a germline BRCA1/2 (gBRCA) mutation. Olaparib resulted in improved p
Autor:
Eva Ciruelos, Antonia Perelló, Santiago González-Santiago, Ana López, Francisco Javier Salvador Bofill, Cinta Albacar, Juan Miguel Cejalvo, Santiago Escrivá-de-Romani, Isabel Blancas, Sonia Pernas, Olga Martínez-Sáez, Josefina Cruz, Jose Ponce, Sonia Servitja, Maria-Eva Perez-Lopez, Juan A Guerra, Esther Sanfeliu, Cesar A Rodríguez, Guillermo Villacampa, Lorea Villanueva, Pablo Tolosa, Tomás Pascual, Aleix Prat
Publikováno v:
Cancer Research. 83:OT2-08
Background Today, there is no clear therapeutic algorithm for patients with metastatic HER2-positive (HER2+) breast cancer (BC) who have progressed to trastuzumab, pertuzumab, tyrosine kinase inhibitors and antibody-drug conjugates (ADC). Among the e
Autor:
Raquel Veiga-Seijo, Sonia Pertega-Diaz, Maria Eva Perez-Lopez, Lourdes Calvo-Martinez, Silvia Antolin Novoa, Cristina Gonzalez-Martin
Background. Chemotherapy is one of the most widely used therapies for breast cancer, triggering important repercussions on people’s quality of life. However, little research has been undertaken about podiatric adverse effects. This study aimed was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1caee780ba31d75de1811e34fe0a045a
https://doi.org/10.21203/rs.3.rs-2665187/v1
https://doi.org/10.21203/rs.3.rs-2665187/v1
Publikováno v:
Journal of Cancer Metastasis and Treatment.
Autor:
Isabel, Gonzalez Yañez, Maria Eva, Perez Lopez, Jose Angel, Rodriguez Lopez, Maria Dolores, Arias Santos, Jesus, Garcia Gomez, Jesus, Garcia Mata
Publikováno v:
Archivos espanoles de urologia. 62(2)
To make the difference between two uncommon entities, small cell prostate carcinoma and prostatic metastasis of small cell lung cancer.We describe a case of single extrapulmonar metastasis in the prostate from small lung carcinoma.We describe a case
Autor:
Isabel Gonzalez Yañez, Jose Angel Rodriguez Lopez, Jesús García Mata, Jesús García Gómez, Maria Dolores Arias Santos, Maria Eva Perez Lopez
Publikováno v:
Archivos Españoles de Urología (Ed. impresa) v.62 n.2 2009
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Objetivo: Diferenciar dos entidades infrecuentes, carcinoma prostático de células pequeñas y metástasis prostática de tumor pulmonar de células pequeñas. Métodos/resultados: Presentamos un caso de carcinoma pulmonar microcítico con una metá
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::926187687be5d397c93152110c4a85aa
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142009000200010
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142009000200010
Publikováno v:
Archivos Españoles de Urología (Ed. impresa) v.60 n.2 2007
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
OBJETIVOS Varon de 67 anos diagnosticado de carcinoma prostatico pT3bN0M0 intervenido (RTU) y tratado con BAC (bloqueo androgenico completo). Presenta bruscamente proptosis y desviacion nasal de ojo izquierdo y leve cefalea hemicraneal y orbitaria iz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e96a2789ffa81e7b30daf36ff75f836
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142007000200019
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142007000200019